Loading...
American Well Corp (AMWL) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock has shown a recent price increase, but the company's financial performance is weak, with declining revenue, net income, and EPS. Insider selling has increased significantly, and analysts have lowered price targets while maintaining hold ratings. While technical indicators show some positive momentum, there are no strong proprietary trading signals or compelling catalysts to justify a buy decision. It is better to hold off on investing in AMWL at this time.
The MACD histogram is positive and expanding, suggesting bullish momentum. RSI is at 72.609, which is in the neutral zone but approaching overbought levels. Moving averages are converging, indicating no clear trend. Key support and resistance levels are Pivot: 5.222, R1: 5.856, S1: 4.588, R2: 6.247, S2: 4.196.

The MACD histogram is positive and expanding, indicating short-term bullish momentum.
Insiders are selling heavily, with a 141.83% increase in selling activity over the last month. Financial performance in Q4 2025 showed significant declines in revenue (-22.11%), net income (-41.57%), and EPS (-45.13%). Analysts have lowered price targets and expressed concerns about revenue decline guidance for 2026.
In Q4 2025, revenue dropped to $55.31M (-22.11% YoY), net income dropped to -$24.92M (-41.57% YoY), EPS dropped to -1.52 (-45.13% YoY), and gross margin dropped to 36.06% (-2.96% YoY).
Analysts have lowered price targets recently: Stifel to $5 from $6, TD Cowen to $5 from $7, and Morgan Stanley to $6 from $10.50. All analysts maintain hold or equal weight ratings, citing concerns about revenue decline guidance and strategic restructuring.